证券记录 · 已归档季度
EWTX
Edgewise Therapeutics, Inc. · Healthcare · Biotechnology
14被追踪持有人
0Δ持有人
7.38M持有股份
$197.14M报告持仓市值
+1新建仓位
−1清仓
动量输入（同类管理人）： 持有人广度 0.0% · 股份流向 -7.1% · 净新建仓位 0.0% · 公式
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q4 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | +1 | 735.20K | $29.85M | +1 | n/a |
| Q2 2026 | 88 | +9 | 40.35M | $1.62B | +14 | −4 |
| Q1 2026 | 81 | +4 | 39.90M | $1.24B | +9 | −6 |
| Q4 2025 | 77 | +2 | 40.83M | $1.01B | +3 | n/a |
| Q3 2025 | 14 | +1 | 17.98M | $291.62M | +1 | −1 |
| Q2 2025 | 11 | -4 | 17.73M | $232.39M | n/a | −4 |
| Q1 2025 | 12 | -2 | 5.61M | $123.36M | n/a | −2 |
| Q4 2024 | 14 | 0 | 7.38M | $197.14M | +1 | −1 |
| Q3 2024 | 13 | +3 | 6.24M | $166.42M | +3 | n/a |
| Q2 2024 | 10 | n/a | 8.30M | $149.57M | n/a | n/a |
持有人 · Q4 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (被动) | 1.72M | n/a | $45.81M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (被动) | 1.60M | +0.1% | $42.74M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 3 | Viking Global Investors ✦ | 1.22M | -17.3% | $32.71M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 4 | Millennium Management ✦ | 888.97K | -9.9% | $23.74M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 5 | D. E. Shaw & Co. ✦ | 686.37K | +50.7% | $18.33M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 6 | Citadel Advisors ✦ | 469.45K | -12.8% | $12.53M | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 7 | Adage Capital Partners ✦ | 240.00K | +1015.8% | $6.41M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 8 | Wellington Management ✦ | 202.89K | -1.2% | $5.42M | 0.0% | ▼ Trim | 3 | SEC ↗ ×4 |
| 9 | Two Sigma Investments ✦ | 131.67K | -49.6% | $3.52M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 10 | Point72 Asset Management ✦ | 106.56K | 新增 | $2.85M | 0.0% | New | 1 | SEC ↗ |
| 11 | Norges Bank ✦ (被动) | 47.76K | 0.0% | $1.28M | 0.0% | Held | 2 | SEC ↗ |
| 12 | Marshall Wace ✦ | 29.89K | -94.8% | $798,142 | 0.0% | ▼ Trim | 3 | SEC ↗ ×3 |
| 13 | T. Rowe Price ✦ | 29.05K | +22.0% | $776,000 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 9.37K | +4.7% | $250,073 | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Point72 Asset Management | $2.85M | 0.0% |
已清仓
| Renaissance Technologies | $733,041 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 213 持有人, 118.39M 股份, $3.71B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Aug 13
Donovan Joanne M.
Officer · 2.92K 股 · $126,704
Aug 12
Derakhshan Behrad
Officer · 2.17K 股 · $95,075
Aug 12
Derakhshan Behrad
Officer · 304 股 · $13,529
Aug 12
Derakhshan Behrad
Officer · 150 股 · $6,666
Aug 12
Derakhshan Behrad
Officer · 2.48K 股 · $108,154
Aug 12
Donovan Joanne M.
Officer · 2.84K 股 · $124,303
Aug 12
Donovan Joanne M.
Officer · 2.78K 股 · $121,463
Aug 12
Donovan Joanne M.
Officer · 104 股 · $4,620
Aug 12
Donovan Joanne M.
Officer · 800 股 · $35,614
Aug 12
KOCH KEVIN
Officer, Director · 8.28K 股 · $361,315
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Aug 14
SC 13G/A: RA CAPITAL MANAGEMENT, L.P.
Aug 14
SC 13G/A: Paradigm Biocapital Advisors LP
Aug 14
SC 13G/A: BAKER BROS. ADVISORS LP
Aug 06
SC 13G: FMR LLC
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q4 2024 ·
方法论 ·
通过API获取此数据